Literature DB >> 12957362

Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array.

Michelle L Swearingen1, Duo Sun, Maureen Bourner, Edward J Weinstein.   

Abstract

The molecular mechanisms involved in the progression of colon carcinomas from a primary to a metastatic tumor have been only partially elucidated and poorly understood. This study combines suppression subtractive hybridization and cDNA array hybridization to identify genes with expression differences between a primary human colon tumor cell line (HT29) and three isogenic lung tumor metastases. The positive clones isolated in this screen were further validated and quantitated with real-time reverse transcription polymerase chain reactions. HES-6 was identified as up-regulated in each of the individual tumor metastases, as well as in a panel of primary human tumors derived from the lung, breast and kidney. These findings demonstrate that it is possible to utilize longitudinal samples from an in vivo model of colon carcinoma to identify genes up-regulated in metastases and that HES-6 may be an important marker of a range of primary cancers as well as metastatic colon carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957362     DOI: 10.1016/s0304-3835(03)00313-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Identification of differently expressed genes in human colorectal adenocarcinoma.

Authors:  Yao Chen; Yi-Zeng Zhang; Zong-Guang Zhou; Gang Wang; Zeng-Ni Yi
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 2.  Molecular characterization of human plasmacytoid dendritic cells.

Authors:  Wei Cao
Journal:  J Clin Immunol       Date:  2009-03-06       Impact factor: 8.317

Review 3.  Recent advances in understanding the role of HES6 in cancers.

Authors:  Imène Krossa; Thomas Strub; Arnaud Martel; Sacha Nahon-Esteve; Sandra Lassalle; Paul Hofman; Stéphanie Baillif; Robert Ballotti; Corine Bertolotto
Journal:  Theranostics       Date:  2022-05-20       Impact factor: 11.600

4.  CCMAlnc Promotes the Malignance of Colorectal Cancer by Modulating the Interaction Between miR-5001-5p and Its Target mRNA.

Authors:  Yuqing Yan; Baoqin Xuan; Ziyun Gao; Chaoqin Shen; Yingying Cao; Jie Hong; Haoyan Chen; Zhe Cui; Guangyao Ye; Jing-Yuan Fang; Zhenhua Wang
Journal:  Front Cell Dev Biol       Date:  2020-12-16

5.  ERCC5, HES6 and RORA are potential diagnostic markers of coronary artery disease.

Authors:  Zhifeng Bai; Yuanyuan Luo; Linyun Tian
Journal:  FEBS Open Bio       Date:  2022-08-07       Impact factor: 2.792

6.  Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.

Authors:  Johan Hartman; Eric W-F Lam; Jan-Ake Gustafsson; Anders Ström
Journal:  Breast Cancer Res       Date:  2009-11-05       Impact factor: 6.466

7.  Identification of up-regulated genes in malignant glioma with subtraction hybridization: preliminary screening studies.

Authors:  Yong Jae Cho
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

8.  Pro-neural transcription factors as cancer markers.

Authors:  Maria Vias; Charlie E Massie; Philip East; Helen Scott; Anne Warren; Zongxiang Zhou; Alexander Yu Nikitin; David E Neal; Ian G Mills
Journal:  BMC Med Genomics       Date:  2008-05-19       Impact factor: 3.063

9.  Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer.

Authors:  Yuandong Xu; Xuejuan Liu; Huizhong Zhang; Ziyuan Zhu; Xianqiu Wu; Xiaobing Wu; Shuling Li; Libing Song; Xuehu Xu
Journal:  Oncol Rep       Date:  2018-07-02       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.